Lilly PACKAGE LABEL - Mounjaro Multi-Dose Vial - 10 mg/0.6 mL Dose (40 mg/2.4 mL [16.7 mg/mL]) Rx Only NDC 0002-4304-11 Mounjaro (tirzepatide) injection 40 mg/2.4 mL (16.7 mg/mL) ATTENTION: Contains 4 doses of 10 mg/0.6 mL 2.4 mL MULTI-DOSE VIAL For Subcutaneous Use Needles and Syringes are not included Dispense enclosed Medication Guide to each patient
When to Contact Us (Seek Medical Advice if You Experience): Fever of 100.4F (38C) or higher Blistering at the injection site Muscle aches, nausea, dizziness, or headache (severe or persistent) Skin rash, severe itching, vomiting, or hives HOW IT WORKS BOOK NOW CJC-1295 is a growth hormone-releasing hormone (GHRH) analog that stimulates the pituitary gland to release growth hormone in a controlled, sustained manner
If results plateau or reverse, the tirzepatide not working anymore troubleshooting guide and weight loss stall analysis cover the most common causes and solutions
Understanding Mounjaro's true mechanism helps clarify its role in comprehensive diabetes management and cardiovascular health optimisation
Not a good time for a call
That structure shows up repeatedly across clinical guidance and top-ranking pages